Aquestive Therapeutics, Inc.
AQST
$4.39
-$0.08-1.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.29% | 69.36% | 65.69% | -32.64% | -27.88% |
| Total Receivables | -34.25% | 141.87% | 21.86% | 97.80% | 25.47% |
| Inventory | 12.06% | 2.07% | 12.29% | 16.64% | -6.93% |
| Prepaid Expenses | 57.35% | 26.84% | 48.33% | 1.61% | 35.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 46.00% | 69.20% | 57.06% | -21.43% | -21.35% |
|
|
|||||
| Total Current Assets | 46.00% | 69.20% | 57.06% | -21.43% | -21.35% |
| Net Property, Plant & Equipment | -6.14% | -5.20% | -5.14% | -6.27% | -6.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.49% | -37.44% | -24.37% | -24.30% | -22.19% |
| Total Assets | 38.04% | 58.17% | 48.75% | -20.33% | -21.07% |
|
|
|||||
| Total Accounts Payable | -3.18% | 190.29% | 43.49% | 109.81% | 16.70% |
| Total Accrued Expenses | 1.35% | -16.10% | 13.21% | -5.45% | -26.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2,426.10% | 1,882.28% | 1,266.47% | 682.25% | 29.75% |
| Total Finance Division Other Current Liabilities | 2.15% | 2.15% | 2.15% | 2.25% | -16.78% |
| Total Other Current Liabilities | 2.15% | 2.15% | 2.15% | 2.25% | -16.78% |
| Total Current Liabilities | 73.53% | 152.36% | 68.78% | 66.64% | 1.33% |
|
|
|||||
| Total Current Liabilities | 73.53% | 152.36% | 68.78% | 66.64% | 1.33% |
| Long-Term Debt | -25.63% | -15.29% | -4.12% | 6.26% | 17.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.03% | -12.98% | -12.01% | -11.12% | -9.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.40% | 8.91% | 3.64% | 2.58% | -6.53% |
| Total Liabilities | 7.36% | 20.12% | 7.91% | 8.63% | -1.60% |
|
|
|||||
| Common Stock & APIC | 29.45% | 36.39% | 36.67% | 9.34% | 10.02% |
| Retained Earnings | -17.85% | -23.07% | -19.93% | -19.44% | -16.34% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 44.11% | 44.04% | 90.95% | -104.60% | -67.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 44.11% | 44.04% | 90.95% | -104.60% | -67.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 44.11% | 44.04% | 90.95% | -104.60% | -67.85% |
|
|
|||||